Search - tctmd.com

Displaying 161 - 180 of 279

Sort: Relevancy | Date

News Industry News TCT 2016

Long-Term Study Results Show that PFO Closure is More Effective Than Medical Management in Preventing Recurrent Stroke

November 01, 2016

News Conference News TCT 2016

Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention

Yael L. Maxwell

November 01, 2016

Presentation TCT 2016

Hot Topic #3: Anti-ischemic Therapy: Beta Blockers, ACE Inhibitors, and Ranolazine - Are They Effective?

Presenter: Bernard J. Gersh, Felix Mahfoud, Ori Ben-Yehuda

November 01, 2016

Presentation TCT 2016

Trial #7 - The Essentials ofCTSN SMR Trial - Two-Year Outcomes Following Mitral Valve Repair or Replacement for Severe Ischemic Mitral Regurgitation

Presenter: William A. Gray, Stephan Windecker, Michael Argenziano

October 31, 2016

Presentation TCT 2016

TCT 94: Impact of Thin-Cap Fibroatheromas on Unanticipated Ischemic Events in Medically Treated Patients With Diabetes Mellitus: Insights From the PROSPECT Study

Presenter: Farouc Jaffer, Amir Lerman, Elvin Kedhi

October 31, 2016

News Conference News TCT 2016

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

Michael O'Riordan

October 31, 2016

Presentation TCT 2016

Role of Papillary Muscle Relocation in Ischemic Mitral Valve Regurgitation

Presenter: Michael J. Mack, Francesco Maisano, Marco Moscarelli

October 30, 2016

Presentation TCT 2016

A Case Series of Ischemic and Nonischemic Leg Ulcers

Presenter: Koen Deloose, Jihad A. Mustapha, Ethan C Korngold

October 30, 2016

News Conference News TCT 2016

LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years

Yael L. Maxwell

October 30, 2016

Presentation TCT 2016

LV Volume Reduction in Post-AMI, Ischemic Heart Failure Patients

Presenter: Oscar A. Mendiz, Giora Weisz, Horst Sievert

October 30, 2016

News Conference News TCT 2016

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

Todd Neale

October 29, 2016

News Opinion Editor's Corner TCT 2015

My Takeaways From TCT 2015

Shelley Wood

October 20, 2015

Presentation TCT 2015

Debate: Are We Really Ready for Phase III Trials? Yes, Mesenchymal Cells Are Ready to Be Tested for Prevention and Treatment of Chronic Ischemic and Nonischemic Heart Failure!

Presenter: Francisco Fdez-Aviles, Timothy D. Henry, Emerson C. Perin

October 15, 2015

News Conference News TCT 2015

RESPECT Confirms Long-term Safety, Efficacy of PFO Closure for Recurrent Stroke

Nicole Lou

October 15, 2015

Presentation TCT 2015

Use of The e-ASPECTS Software on Noncontrast CT Scans for Automated Detection of Acute Ischemic Stroke

Presenter: Leo Nelson Hopkins, Horst Sievert, Christine Roffe

October 14, 2015

Presentation TCT 2015

Initial Clinical Results of Transcatheter Technique for LV Volume Reduction Treatment of Ischemic Cardiomyopathy

Presenter: Andrea Abizaid, Daniel Burkhoff, Salvatore Brugaletta

October 14, 2015

Presentation TCT 2015

Percutaneous Transluminal Caval Flow Restriction With Counterpulsation Balloon in Ischemic and Nonischemic Heart Failure Patients

Presenter: Andrea Abizaid, Daniel Burkhoff, Jose E. Herrera

October 14, 2015

News Conference News TCT 2015

CREST-2 Triggers Spirited Debate on Merits of CAS vs. CEA

Todd Neale

October 14, 2015

Presentation TCT 2015

TCT 58: Immediate and Long-term Outcomes of Ischemic Versus Nonischemic Functional Mitral Regurgitation in Patients Treated With MitraClip Insights From the 2011-12 Pilot European Sentinel Registry of Percutaneous Edge-to-Edge Mitral Valve Repair

Presenter: Jacqueline Saw, Steven J. Yakubov, Michele Pighi

October 13, 2015

Presentation TCT 2015

TCT 32: Percutaneous Ventricular Restoration (PVR) Therapy Using the Parachute Device in Patients With Ischemic Dilated Heart Failure Two-Year Results of the PARACHUTE III European Postmarket Trial

Presenter: John P. Cheatham, Carlos Pedra, Ulrich Schaefer

October 13, 2015

Advertisement

Long-Term Study Results Show that PFO Closure is More Effective Than Medical Management in Preventing Recurrent Stroke

Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention

Hot Topic #3: Anti-ischemic Therapy: Beta Blockers, ACE Inhibitors, and Ranolazine - Are They Effective?

Trial #7 - The Essentials ofCTSN SMR Trial - Two-Year Outcomes Following Mitral Valve Repair or Replacement for Severe Ischemic Mitral Regurgitation

TCT 94: Impact of Thin-Cap Fibroatheromas on Unanticipated Ischemic Events in Medically Treated Patients With Diabetes Mellitus: Insights From the PROSPECT Study

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

Role of Papillary Muscle Relocation in Ischemic Mitral Valve Regurgitation

A Case Series of Ischemic and Nonischemic Leg Ulcers

LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years

LV Volume Reduction in Post-AMI, Ischemic Heart Failure Patients

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

My Takeaways From TCT 2015

Debate: Are We Really Ready for Phase III Trials? Yes, Mesenchymal Cells Are Ready to Be Tested for Prevention and Treatment of Chronic Ischemic and Nonischemic Heart Failure!

RESPECT Confirms Long-term Safety, Efficacy of PFO Closure for Recurrent Stroke

Use of The e-ASPECTS Software on Noncontrast CT Scans for Automated Detection of Acute Ischemic Stroke

Initial Clinical Results of Transcatheter Technique for LV Volume Reduction Treatment of Ischemic Cardiomyopathy

Percutaneous Transluminal Caval Flow Restriction With Counterpulsation Balloon in Ischemic and Nonischemic Heart Failure Patients

CREST-2 Triggers Spirited Debate on Merits of CAS vs. CEA

TCT 58: Immediate and Long-term Outcomes of Ischemic Versus Nonischemic Functional Mitral Regurgitation in Patients Treated With MitraClip Insights From the 2011-12 Pilot European Sentinel Registry of Percutaneous Edge-to-Edge Mitral Valve Repair

TCT 32: Percutaneous Ventricular Restoration (PVR) Therapy Using the Parachute Device in Patients With Ischemic Dilated Heart Failure Two-Year Results of the PARACHUTE III European Postmarket Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content